The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance

Abstract excerpt

Abstract KDM4 and JMJD2 are histone demethylases that are considered promising targets for treatment of MLL translocation–bearing acute myeloid leukemia. Agger and colleagues demonstrate an important role of KDM4 activity in long-term normal hematopoiesis that should be considered when contemplating the clinical use of long-term inhibition of KDM4 demethylase activity.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epigenetics and DNA Methylation
• Share to Hematopoietic Stem Cell Transplantation
• Share to Histone Deacetylase Inhibitors Research